Drug Shortage Report for TARO-TEMOZOLOMIDE

Last updated on 2021-08-24 History
Report ID 142452
Drug Identification Number 02443554
Brand name TARO-TEMOZOLOMIDE
Common or Proper name TEMOZOLOMIDE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TEMOZOLOMIDE
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 5
ATC code L01AX
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-01
Estimated end date 2021-08-27
Actual end date 2021-08-23
Shortage status Resolved
Updated date 2021-08-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-08-24 French Compare
v9 2021-08-24 English Compare
v8 2021-08-20 French Compare
v7 2021-08-20 English Compare
v6 2021-08-04 French Compare
v5 2021-08-04 English Compare
v4 2021-07-19 French Compare
v3 2021-07-19 English Compare
v2 2021-07-13 French Compare
v1 2021-07-13 English Compare

Showing 1 to 10 of 10